CAS : 74755-21-8
ProductName : Sodium 4-((4-chlorobenzoyl)(4-methoxyphenyl)amino)butyrate
Schering-Plough Animal Health Limited ACN 000 235 245
Material Safety Data Sheet Issue Date: August 2001
Product Name: BYKAHEPA
Not Classified as Hazardous according to criteria of Worksafe Australia
COMPANY DETAILS
Company Name SCHERING-PLOUGH ANIMAL HEALTH LIMITE Address 11 GIBBON ROAD BAULKHAM HILLS NSW 2153
Emergency Telephone 1800 226 511 (24 HR)
Tel/Fax Ph: (02) 9852 7200 Fax: (02) 9852 7285
Other Information This MSDS has been transcribed into Worksafe Australia format from an original issued by the
manufacturer on the date shown above.
IDENTIFICATION
Product Name BYKAHEPA
Shipping Name (CSN) Not considered a dangerous good and no UN number allocated
Other Names Name Mancode
Clanobutin injection
4-((4-Chlorobenzoyl)(4-methoxyphenyl)amino)butanoic acid, sodium salt
UN Number Not Regulated
DG Class Not Regulated
Sub. Risk Not Regulated
Packaging Group Not Regulated
Hazchem Code Not Regulated
Poisons Schedule S4
Product Use Digestive stimulant.
Physical Data
Appearance A colourless, clear aqueous solution.
Approximately 1000C
Boiling Point
Vapour Pressure Not available
~1.0 at 150C
Specific Gravity
Flash Point Non flammable
Flamm. Limit LEL Non flammable
Other Properties
Form Liquid
Other Information Solubility in water (g/L): Miscible
Ingredients
Ingredients Name CAS Proportion
Clanobutin , Sodium Salt 74755-21-8 10.64%
Schering-Plough Animal Health Limited ACN 000 235 245
Material Safety Data Sheet Issue Date: August 2001
Product Name: BYKAHEPA
Not Classified as Hazardous according to criteria of Worksafe Australia
HEALTH HAZARD INFORMATION
Health Effects
Acute - Ingestion May cause irritation to the gastrointestinal tract, with possible effects of upset stomach, nausea,
vomiting and diarrhoea.
Acute - Eye May cause irritation to the eyes, with effects including watering and tearing, pain and possible
burning
Acute - Skin May cause irritation to the skin. This material is not anticipated to be absorbed through the skin.
Acute - Inhalation May cause irritation to the respiratory tract.
Chronic May cause reddening of the skin or possible dermatitis in some susceptible individuals.
First Aid
Ingestion Thoroughly rinse mouth with water. If poisoning occurs contact a doctor or Poisons Information
Centre (Phone 113126). Do not make an unconscious person vomit. If vomiting occurs, place
victim face downward, head lower than hips, to prevent aspiration of material into the lungs.
Eye Irrigate with copious quantities of water for 15 minutes. Eyelids to be held open. Seek immediate
medical attention.
Skin Remove ALL contaminated clothing and wash skin thoroughly with soap and water. . If irritation
persists see a doctor.
Inhalation Remove victim from further exposure. Avoid becoming a casualty. Seek medical advice.
Other Information A first aid kit should be readily available, with eye bath.
Advice to Doctor
Advice to Doctor Show this MSDS to the Doctor. Treat respiratory depression with assisted respiration. In severe
Hypotension, the circulation should be maintained with infusions of plasma or suitable electrolyte
Solutions.
PRECAUTIONS FOR USE
Exposure Limits Name STEL TWA
mg/m3 ppm mg/m3 ppm TWA Footnote
None assigned to the product.
Other Exposure Info. None assigned to the product.
Engineering Controls Avoid generating mists or vapours. The use of natural ventilation systems are adequate unless the
material is heated, then the use of a local exhaust ventilation system is recommended.
Schering-Plough Animal Health Limited ACN 000 235 245
Material Safety Data Sheet Issue Date: August 2001
Product Name: BYKAHEPA
Not Classified as Hazardous according to criteria of Worksafe Australia
Personal Protection
Protective Equipment If large quantities of this product are being handled, for example, in industrial environments then it
is recommended that protective clothing, gloves, chemical goggles or face shield, and respiratory
protection be worn. Select and use respirators in accordance with AS/NZS 1715. When high vapour
or mist levels are suspected then the use of the following: A half face piece respirator with organic
vapour (Type A) and dust/mist (Type P1) canister type is recommended. Filter capacity and
respirator type depends on exposure levels. If entering spaces where the airborne concentration of
a contaminate is unknown then the use of an Self-contained breathing apparatus (SCBA) complying
with AS 1715 is recommended.
Flammability
Fire Hazards Non-flammable.
SAFE HANDLING INFORMATION
Storage and Transport
Storage Precautions STORAGE: The product is a Scheduled Poison (S4) and therefore must be stored and maintained
and used in accordance with the relevant State Poisons Act. Store below 250C (air conditioning).
Protect from light. Do not refrigerate. TRANSPORT: Bykahepa is not classified as a Dangerous
Good for the purpose of road and rail transport.
Shipping Name (CSN) Not considered a dangerous good and no UN number allocated.
Spills and Disposal
Spills and Leaks Clear area of all unprotected personnel. Work up wind. Increase ventilation. Wear full protective
equipment to prevent skin and eye contamination and inhalation of vapours. Bund area using sand
or earth, prevent run off into drains and waterways. Collect and seal in properly labelled drums for
disposal. In the event of a contamination of sewers or waterways, notify the local environment
protection authority or emergency services. DISPOSAL: Refer to State Land Waste Management
Authority. Suitable for incineration by approved agent
Fire/Explosion Hazard
Fire/Explos. Hazards Use water spray to cool fire exposed surfaces and to protect personnel, Shut off 'fuel' to fire.
Hazardous Decomposition Products: Oxides of carbon, chlorine and noxious smoke. Fire Fighting
Procedures: Fire fighters to wear Self-contained breathing apparatus (SCBA) in confined spaces,
where oxygen deficient atmospheres exist or if exposure to hazardous combustion products may
occur. Extinguishing Media: Use foam, Carbon dioxide or dry chemical agent. Stability: Stable,
under normal conditions of use. Hazardous Polymerization: Will not occur.
Materials to Avoid: Strong oxidising agents. Non-flammable. In a severe fire may emit toxic or irritant fumes. If
involved in a fire, use foam carbon dioxide or dry chemical powder.
Hazchem Code Not regulated
Schering-Plough Animal Health Limited ACN 000 235 245
Material Safety Data Sheet Issue Date: August 2001
Product Name: BYKAHEPA
Not Classified as Hazardous according to criteria of Worksafe Australia
OTHER INFORMATION
Toxicology Clanobutin Toxicity: Rat - LD50: (Intravenous) 570 mg/kg (German Offenlegungsschrift Patent
Document.; U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231,
#1917036). Mouse - LD50 (Intravenous) DOSE: 54.7 mg/kg; LD50 (Oral) >2 g/kg [United States
Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) (#3780095)].
Environmental Protection Refer to the Environmental Protection Authority.
Safety Statement
CONTACT POINT
Contact CUSTOMER SERVICE: 1800 226 511
This Material Safety Data Sheet and the information contained herein is provided for the sole
purpose of enabling persons handling and using the product to do so with safety. Any other use of
this information is prohibited and may constitute an infringement of certain rights of Schering-
Plough Animal Health Limited. No rights to this information are given to any person by virtue of
the provision of this Material Safety Data Sheet. The information provided herein is believed to be
accurate at the time of writing but can be subject to change. No warranty, express or implied, is
made as to its accuracy, completeness or otherwise and no assumption of liability howsoever arising
is made by Schering-Plough Animal Health Limited by reason of the provision of this information.
Every person dealing with the materials referred to herein or the information provided herein does
so at their own risk absolutely and should make independent determinations of the suitability or
completeness of information from all sources to assure their proper use.
User Information TWA - is the time weighted average concentration of the work atmosphere for a normal 8-hour
work day and a 40-hour work week, to which nearly all workers can be repeatedly exposed without
adverse effect. CAS - Chemical Abstracts Service Registry Number.
...End of Report??
Material Safety Data Sheet Issue Date: August 2001
Product Name: BYKAHEPA
Not Classified as Hazardous according to criteria of Worksafe Australia
COMPANY DETAILS
Company Name SCHERING-PLOUGH ANIMAL HEALTH LIMITE Address 11 GIBBON ROAD BAULKHAM HILLS NSW 2153
Emergency Telephone 1800 226 511 (24 HR)
Tel/Fax Ph: (02) 9852 7200 Fax: (02) 9852 7285
Other Information This MSDS has been transcribed into Worksafe Australia format from an original issued by the
manufacturer on the date shown above.
IDENTIFICATION
Product Name BYKAHEPA
Shipping Name (CSN) Not considered a dangerous good and no UN number allocated
Other Names Name Mancode
Clanobutin injection
4-((4-Chlorobenzoyl)(4-methoxyphenyl)amino)butanoic acid, sodium salt
UN Number Not Regulated
DG Class Not Regulated
Sub. Risk Not Regulated
Packaging Group Not Regulated
Hazchem Code Not Regulated
Poisons Schedule S4
Product Use Digestive stimulant.
Physical Data
Appearance A colourless, clear aqueous solution.
Approximately 1000C
Boiling Point
Vapour Pressure Not available
~1.0 at 150C
Specific Gravity
Flash Point Non flammable
Flamm. Limit LEL Non flammable
Other Properties
Form Liquid
Other Information Solubility in water (g/L): Miscible
Ingredients
Ingredients Name CAS Proportion
Clanobutin , Sodium Salt 74755-21-8 10.64%
Schering-Plough Animal Health Limited ACN 000 235 245
Material Safety Data Sheet Issue Date: August 2001
Product Name: BYKAHEPA
Not Classified as Hazardous according to criteria of Worksafe Australia
HEALTH HAZARD INFORMATION
Health Effects
Acute - Ingestion May cause irritation to the gastrointestinal tract, with possible effects of upset stomach, nausea,
vomiting and diarrhoea.
Acute - Eye May cause irritation to the eyes, with effects including watering and tearing, pain and possible
burning
Acute - Skin May cause irritation to the skin. This material is not anticipated to be absorbed through the skin.
Acute - Inhalation May cause irritation to the respiratory tract.
Chronic May cause reddening of the skin or possible dermatitis in some susceptible individuals.
First Aid
Ingestion Thoroughly rinse mouth with water. If poisoning occurs contact a doctor or Poisons Information
Centre (Phone 113126). Do not make an unconscious person vomit. If vomiting occurs, place
victim face downward, head lower than hips, to prevent aspiration of material into the lungs.
Eye Irrigate with copious quantities of water for 15 minutes. Eyelids to be held open. Seek immediate
medical attention.
Skin Remove ALL contaminated clothing and wash skin thoroughly with soap and water. . If irritation
persists see a doctor.
Inhalation Remove victim from further exposure. Avoid becoming a casualty. Seek medical advice.
Other Information A first aid kit should be readily available, with eye bath.
Advice to Doctor
Advice to Doctor Show this MSDS to the Doctor. Treat respiratory depression with assisted respiration. In severe
Hypotension, the circulation should be maintained with infusions of plasma or suitable electrolyte
Solutions.
PRECAUTIONS FOR USE
Exposure Limits Name STEL TWA
mg/m3 ppm mg/m3 ppm TWA Footnote
None assigned to the product.
Other Exposure Info. None assigned to the product.
Engineering Controls Avoid generating mists or vapours. The use of natural ventilation systems are adequate unless the
material is heated, then the use of a local exhaust ventilation system is recommended.
Schering-Plough Animal Health Limited ACN 000 235 245
Material Safety Data Sheet Issue Date: August 2001
Product Name: BYKAHEPA
Not Classified as Hazardous according to criteria of Worksafe Australia
Personal Protection
Protective Equipment If large quantities of this product are being handled, for example, in industrial environments then it
is recommended that protective clothing, gloves, chemical goggles or face shield, and respiratory
protection be worn. Select and use respirators in accordance with AS/NZS 1715. When high vapour
or mist levels are suspected then the use of the following: A half face piece respirator with organic
vapour (Type A) and dust/mist (Type P1) canister type is recommended. Filter capacity and
respirator type depends on exposure levels. If entering spaces where the airborne concentration of
a contaminate is unknown then the use of an Self-contained breathing apparatus (SCBA) complying
with AS 1715 is recommended.
Flammability
Fire Hazards Non-flammable.
SAFE HANDLING INFORMATION
Storage and Transport
Storage Precautions STORAGE: The product is a Scheduled Poison (S4) and therefore must be stored and maintained
and used in accordance with the relevant State Poisons Act. Store below 250C (air conditioning).
Protect from light. Do not refrigerate. TRANSPORT: Bykahepa is not classified as a Dangerous
Good for the purpose of road and rail transport.
Shipping Name (CSN) Not considered a dangerous good and no UN number allocated.
Spills and Disposal
Spills and Leaks Clear area of all unprotected personnel. Work up wind. Increase ventilation. Wear full protective
equipment to prevent skin and eye contamination and inhalation of vapours. Bund area using sand
or earth, prevent run off into drains and waterways. Collect and seal in properly labelled drums for
disposal. In the event of a contamination of sewers or waterways, notify the local environment
protection authority or emergency services. DISPOSAL: Refer to State Land Waste Management
Authority. Suitable for incineration by approved agent
Fire/Explosion Hazard
Fire/Explos. Hazards Use water spray to cool fire exposed surfaces and to protect personnel, Shut off 'fuel' to fire.
Hazardous Decomposition Products: Oxides of carbon, chlorine and noxious smoke. Fire Fighting
Procedures: Fire fighters to wear Self-contained breathing apparatus (SCBA) in confined spaces,
where oxygen deficient atmospheres exist or if exposure to hazardous combustion products may
occur. Extinguishing Media: Use foam, Carbon dioxide or dry chemical agent. Stability: Stable,
under normal conditions of use. Hazardous Polymerization: Will not occur.
Materials to Avoid: Strong oxidising agents. Non-flammable. In a severe fire may emit toxic or irritant fumes. If
involved in a fire, use foam carbon dioxide or dry chemical powder.
Hazchem Code Not regulated
Schering-Plough Animal Health Limited ACN 000 235 245
Material Safety Data Sheet Issue Date: August 2001
Product Name: BYKAHEPA
Not Classified as Hazardous according to criteria of Worksafe Australia
OTHER INFORMATION
Toxicology Clanobutin Toxicity: Rat - LD50: (Intravenous) 570 mg/kg (German Offenlegungsschrift Patent
Document.; U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231,
#1917036). Mouse - LD50 (Intravenous) DOSE: 54.7 mg/kg; LD50 (Oral) >2 g/kg [United States
Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) (#3780095)].
Environmental Protection Refer to the Environmental Protection Authority.
Safety Statement
CONTACT POINT
Contact CUSTOMER SERVICE: 1800 226 511
This Material Safety Data Sheet and the information contained herein is provided for the sole
purpose of enabling persons handling and using the product to do so with safety. Any other use of
this information is prohibited and may constitute an infringement of certain rights of Schering-
Plough Animal Health Limited. No rights to this information are given to any person by virtue of
the provision of this Material Safety Data Sheet. The information provided herein is believed to be
accurate at the time of writing but can be subject to change. No warranty, express or implied, is
made as to its accuracy, completeness or otherwise and no assumption of liability howsoever arising
is made by Schering-Plough Animal Health Limited by reason of the provision of this information.
Every person dealing with the materials referred to herein or the information provided herein does
so at their own risk absolutely and should make independent determinations of the suitability or
completeness of information from all sources to assure their proper use.
User Information TWA - is the time weighted average concentration of the work atmosphere for a normal 8-hour
work day and a 40-hour work week, to which nearly all workers can be repeatedly exposed without
adverse effect. CAS - Chemical Abstracts Service Registry Number.
...End of Report??
sodium 4-[(4-chlorobenzoyl)(4-methoxyphenyl)amino]butyrate
China (Mainland)] 
Assessed
Assessed
Assessed
Assessed
Assessed
Premium